220 related articles for article (PubMed ID: 12409983)
1. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
[TBL] [Abstract][Full Text] [Related]
2. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR
J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy.
Sheu JR; Hsiao G; Lin WY; Chen TF; Chien YY; Lin CH; Tzeng CR
J Biomed Sci; 2002; 9(1):17-25. PubMed ID: 11810021
[TBL] [Abstract][Full Text] [Related]
4. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
Liao CH; Ko FN; Wu CL; Teng CM
J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH
Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946
[TBL] [Abstract][Full Text] [Related]
8. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.
Sheu JR; Lee CR; Lin CC; Kan YC; Lin CH; Hung WC; Lee YM; Yen MH
Br J Pharmacol; 1999 Jul; 127(5):1206-12. PubMed ID: 10455267
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
13. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of U46619 induced human platelet aggregation by aspirin.
Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
[TBL] [Abstract][Full Text] [Related]
15. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
Francesconi M; Scapin M; Casonato A; Girolami A; Deana R
Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the antiplatelet activity of ketamine in human platelets.
Chang Y; Chen TL; Wu GJ; Hsiao G; Shen MY; Lin KH; Chou DS; Lin CH; Sheu JR
J Biomed Sci; 2004; 11(6):764-72. PubMed ID: 15591773
[TBL] [Abstract][Full Text] [Related]
17. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C.
Sheu JR; Kan YC; Hung WC; Su CH; Lin CH; Lee YM; Yen MH
Thromb Res; 1998 Oct; 92(2):53-64. PubMed ID: 9792112
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
[TBL] [Abstract][Full Text] [Related]
20. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
